Biomed Realty and Illumina Announce New Build-to-Suit Laboratory Building
News Jun 26, 2015
BioMed Realty Trust, Inc. has announced that Illumina, Inc. has signed a 20-year lease for a 155,000 square foot new and innovative scientific research building in Cambridge, England. The project will provide Illumina a collaborative environment and access to the highly skilled workforce in the dynamic research cluster anchored by Cambridge University.
The project advances design, with plans to be able to seamlessly expand by 70,000 square feet into a 225,000 square foot building. BioMed Realty acquired the land for the project from The Welding Institute under a long term ground lease, enlarging BioMed Realty’s Granta Park campus in Cambridge, England.
“Illumina and BioMed Realty’s commitment to building a new state-of-the art facility in Cambridge is great news for our area,” said George Freeman, UK Minister for Life Sciences. “This is a strong endorsement of the UK’s Life Science Industrial Strategy and leadership in driving forward better treatments for people with cancers and rare diseases.”
“Illumina is proud of its heritage and presence in the Cambridge area, and welcomes the opportunity to continue our strong investment in the UK,” said Marc Stapley, Chief Financial Officer for Illumina. “This new state-of-the-art European Headquarters will provide enhanced collaboration opportunities for our growing employee base, which is so foundational to Illumina’s innovation and success.”
BioMed Realty owns, manages and operates Granta Park, a scientific research center, located eight miles from Cambridge University and currently comprising 472,200 square feet of laboratory and office space. Last year, the company acquired a 42,400 square foot build-to-suit property in development for Takeda Pharmaceutical Company in the Cambridge Science Park. With today’s announcement of Illumina’s new building, BioMed Realty’s presence in the Cambridge, England market is approaching 700,000 square feet.
“BioMed Realty is delighted to announce that Illumina has selected Granta Park as its European headquarters and to be expanding our relationship with Illumina into Europe,” said Alan Gold, Chairman, President and CEO of BioMed Realty. “Cambridge shares key common characteristics with our core U.S. markets which is why we decided to enter the market and why we continue to grow there.”
DNA Methylation Related to Liver Disease in Obese PatientsNews
DNA methylation implicated in initiation of liver fibrosis in non-alcoholic fatty liver diseaseREAD MORE
UCL Technology Fund Investment MeiraGTx Raises $75 Million in IPONews
MeiraGTx Holdings plc raised $75 million of gross proceeds upon close of the company’s initial public offering (IPO).READ MORE
International Conference on Neurooncology and Neurosurgery
Sep 17 - Sep 18, 2018